2017 Universal Access & Affordable Medicines Forum of the European Public Health Alliance (EPHA)
FOR BETTER AND AFFORDABLE MEDICINES FOR EUROPE
Under the auspices of the Bulgarian Ministry of Health
November 21, 2017 • 9AM – 6PM
Martin’s Brussels EU Hotel
Boulevard Charlemagne 80, 1000 Brussels
#GameChangers was a day full of stimulating and lively discussions on the hottest topics in the access to medicines debate:
– Incentives in drug development: Towards profiteering or genuine innovation?
– The push for accelerated approvals: Speed and deregulation over patient safety and robust evidence?
– Transparency in pharmaceuticals: Desirable &/or feasible?
– Business strategies, anti-competitive practices & medicines’ shortages: What is the way out?
About the event
08.45 – 09.15
REGISTRATION AND COFFEE
09.15 – 09.45
09.45 – 11.15
PANEL 1: Transparency in pharmaceuticals: desirable and/or feasible?
11.30 – 13.00
PANEL 2: Drug development: do the incentives work?
13.45 – 15.15
PANEL 3: The push for accelerated drug approvals: speed and deregulation over patient safety and robust evidence?
15.30 – 17.00
PANEL 4: Business strategies, anti-competitive practices & medicines’ shortages: what is the way out?
Representative of the Ministry of Health, Bulgaria
Director Responsible for Health Systems, Medical Products and Innovation, Directorate-General for Health and Food Safety (DG SANTE), European
Policy Manager, Universal Access and Affordable Medicines, European Public Health Alliance (EPHA)
Dr Andrew Hill,
Senior Visiting Research Fellow, Department of Pharmacology and Therapeutics, Liverpool University
Dr Síle Lane,
Head, International Campaigns and Policy, Sense about Science, UK
Head, Pharmaceutical Department, National Institute for Health and Disability Insurance (RIZIV INAMI)
Senior Policy Advisor, Pricing and Reimbursement-Coordinator of the BeNeLuxA Initiative on Pharmaceutical Policy, Ministry of Health, Welfare and Sport,
Director, Public Policy for Europe and Canada, MSD
Professor of Pharmacoeconomics, School of Healthcare Sciences, Bangor University, Co-Director, Centre for Health Economics & Medicines Evaluation
Executive Director, Access Campaign, Médecins Sans Frontières (MSF)
Executive Director Public Affairs European Federation of Pharmaceutical Industries and Associations, EFPIA
Advisor, Netherlands Authority for Consumers and Markets (ACM)
Director, Ludwig Boltzmann Institute for Health Technology Assessment
Researcher, Department of Epidemiology, Regional Health Service,
Patient Advocate, HIV i-Base
Head, Department of Drug Assessment, Institute for Quality and Efficiency in Health Care
Unit B5 – Medicines: policy, authorisation and monitoring DG Santé,
President, Medicines for Europe
Vice-President, European Association of Hospital Pharmacists (EAHP)
Senior Expert on Health Care Policies, Impeller of the Association for a Fair Access to Medicines, Spain
Member, Romanian Health Observatory
Head of Unit for Antitrust Pharma and Health services, Directorate General for Competition (DG COMP), European Commission
Re-live the event
In the Press
Re-live the online discussion
Healthy Innovation for all
The 2016 Universal Access and Affordable Medicines Forum of the European Public Health Alliance
Organised under the auspices of the Polish Permanent Representation to the EU
Thank you to all the #GameChangers who joined us on 21 November!
EPHA in your inbox!